These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14446734)

  • 1. Laboratory and clinical observations with a new sulfonylurea.
    SILVER AA; WISHINSKY H; CAPLAN RF; MONK C
    Ann N Y Acad Sci; 1959 Sep; 82():624-31. PubMed ID: 14446734
    [No Abstract]   [Full Text] [Related]  

  • 2. Metahexamide in diabetes therapy.
    MOSS JM; DELAWTER D
    Ann N Y Acad Sci; 1959 Sep; 82():614-7. PubMed ID: 14424617
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on the use of metahexamide in the oral treatment of diabetes mellitus].
    MUCCI A; LUCCHI R; DI MARCO G
    Minerva Med; 1961 Jan; 52():258-63. PubMed ID: 13773420
    [No Abstract]   [Full Text] [Related]  

  • 4. [A contribution to late results of sulfonylurea therapy].
    BIBERGEIL H
    Med Klin; 1961 Oct; 56():1786-91. PubMed ID: 13868940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical indications and contraindications for peroral therapy of diabetics with sulfonylurea preparations].
    STRAUZENBERG SE; HALLER H
    Z Gesamte Inn Med; 1959 Jun; 14():529-33. PubMed ID: 13835158
    [No Abstract]   [Full Text] [Related]  

  • 6. [The results of testing in administration of a new sulfonylurea derivative (metzhexamide) in oral diabetes therapy].
    HUHN R; MAIBAUER D
    Arztl Forsch; 1960 May; 14():I/269-70. PubMed ID: 14403908
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of metahexamide in human plasma.
    FORIST AA
    Ann N Y Acad Sci; 1959 Sep; 82():496-501. PubMed ID: 13823959
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation between structure of sulfonylurea compounds and their effect on frog muscle metabolism.
    GOURLEY DR
    Proc Soc Exp Biol Med; 1958 Oct; 99(1):69-71. PubMed ID: 13601770
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of the half life of metahexamide in normal humans.
    MORGENSTERN LL; GARRETT ER
    Ann N Y Acad Sci; 1959 Sep; 82():502-7. PubMed ID: 14424136
    [No Abstract]   [Full Text] [Related]  

  • 10. [New indications for sulfonylureas?].
    LEUTIGER H
    Med Welt; 1962 Aug; 33():1698-1700. PubMed ID: 14464451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Orv Hetil; 1961 Jul; 102():1405-10. PubMed ID: 13759341
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the effects of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Munch Med Wochenschr; 1962 Feb; 104():226-34. PubMed ID: 14462647
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental studies on the mechanism of the therapeutic effect of antidiabetic sulfonyl-urea].
    OHONO T
    Nihon Naibunpi Gakkai Zasshi; 1961 Nov; 37():869-95. PubMed ID: 14481417
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.
    PFEIFFER EF; PFEIFFER M; DITSCHUNEIT H; AHN CS
    Ann N Y Acad Sci; 1959 Sep; 82():479-95. PubMed ID: 14432532
    [No Abstract]   [Full Text] [Related]  

  • 15. [First clinical trials of a new synthetic antidiabetic SB 1 or 1-(3-aminobenzenesulfonyl)-3-n-butylurea].
    BICKEL G; KORALNIK O
    Schweiz Med Wochenschr; 1959 Nov; 89():1186-91. PubMed ID: 13800475
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacology and clinical responses to metahexamide.
    HAMWI GJ; SKILLMAN TG; KRUGER FA; ROUSH WH; FREEDY LR
    Ann N Y Acad Sci; 1959 Sep; 82():547-59. PubMed ID: 14399399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with the therapeutic use of a new sulfanylurea: N-propyl-N-(p-chlorobenzensulfonyl) urea-P607-by oral route in diabetes mellitus].
    SIGNORELLI S; POLOSA P
    Minerva Med; 1959 Aug; 50():2535-42. PubMed ID: 14446587
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of controlling blood picture in the continuous treatment of diabetic patients with sulfonylurea preparations].
    BLOECH J; KOENIGSTEIN RP; LACKNER P; LENHARDT A; MAEHR G
    Wien Klin Wochenschr; 1962 Feb; 74():94-5. PubMed ID: 13870067
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of sulfonylurea preparations on angina pectoris and intermittent claudication in diabetic subjects.
    FABRYKANT M; ASHE BI
    N Y State J Med; 1960 Mar; 60():841-5. PubMed ID: 13821251
    [No Abstract]   [Full Text] [Related]  

  • 20. ["Diabetic states" in pregnancy and their treatment with sulfonylurea derivatives. (Preliminary note)].
    LOPEZ-FERNANDIZ JR
    Hisp Med; 1960 Sep; 17():423-9. PubMed ID: 13763473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.